Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.3M Sell
1,312,300
-613,800
-32% -$6.55M 0.03% 441
2026
Q1
$21.4M Buy
1,926,100
+813,000
+73% +$10.4M 0.05% 339
2025
Q4
$18.2M Buy
1,113,100
+519,500
+88% +$8.09M 0.03% 400
2025
Q3
$7.94M Sell
593,600
-879,900
-60% -$10.4M 0.01% 805
2025
Q2
$18.9M Buy
1,473,500
+816,400
+124% +$9.79M 0.03% 402
2025
Q1
$6.77M Buy
657,100
+44,300
+7% +$570K 0.02% 749
2024
Q4
$7.79M Buy
+612,800
New +$8.1M 0.02% 684

Other funds holding PATH

PEAK6's PATH Position: Q2 2026 in Review

PEAK6 reduced its UiPath (PATH) stake by 58% in Q2 2026, selling an estimated $6.58M and leaving 437,828 shares worth $4.76M. The position accounts for 0.01% of the portfolio, ranked #877.

PEAK6 first reported a position in PATH in Q2 2025 and has held it in 4 quarters since. The position peaked at $11.7M in Q1 2026. 529 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • PEAK6 held 437,828 shares of UiPath worth $4.76M as of Q2 2026.
  • PEAK6 sold 616,587 UiPath shares in Q2 2026, an estimated $6.58M.
  • UiPath made up 0.01% of PEAK6's portfolio in Q2 2026, its #877 holding.
  • PEAK6 first reported a position in UiPath in Q2 2025 and has held it in 4 quarters since.
  • PEAK6's UiPath position peaked at $11.7M in Q1 2026.
  • 529 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.